Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods? (Q34458340)

2 August 2017

1 reference

title

Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods? (English)

1 reference

2 August 2017

1 reference

Tod MM

1

1 reference

2 August 2017

Padoin C

series ordinal

2

1 reference

2 August 2017

Petitjean O

series ordinal

3

1 reference

2 August 2017

1 January 2001

1 reference

Clinical Pharmacokinetics

2 August 2017

1 reference

2 August 2017

40

1 reference

2 August 2017

803-814

1 reference

2 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200140110-00002

2 August 2017

0 references

cites work

The backpropagation neural network--a Bayesian classifier. Introduction and applicability to pharmacokinetics

1 reference

12 December 2020

Neural network predicted peak and trough gentamicin concentrations.

1 reference

12 December 2020

Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity

1 reference

12 December 2020

Computers in pharmacokinetics. Choosing software for clinical decision making

1 reference

12 December 2020

Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy

1 reference

12 December 2020

Predictive performance of the Bayesian analysis: effects of blood sampling time, population parameters, and pharmacostatistical model

1 reference

12 December 2020

Nonparametric meta-analysis of published data on kidney-function dependence of pharmacokinetic parameters for the aminoglycoside netilmicin

1 reference

12 December 2020

Wide interpatient variations in gentamicin dose requirements for geriatric patients

1 reference

12 December 2020

Aminoglycoside pharmacokinetics: volume of distribution in specific adult patient subgroups

1 reference

12 December 2020

The evaluation of creatinine clearance in spinal cord injury patients

1 reference

12 December 2020

Some international approaches to aminoglycoside monitoring in the extended dosing interval era.

1 reference

12 December 2020

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

1 reference

12 December 2020

Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies

1 reference

12 December 2020

The pharmacokinetics of prophylactic antibiotics in trauma

1 reference

12 December 2020

Aminoglycoside forecasting in neutropenic patients with cancer

1 reference

12 December 2020

Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study

1 reference

12 December 2020

Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?

1 reference

12 December 2020

Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens.

1 reference

12 December 2020

1 reference

12 December 2020

Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model

1 reference

12 December 2020

Cost considerations in therapeutic drug monitoring of aminoglycosides

1 reference

12 December 2020

Increased aminoglycoside dosage requirements in hematologic malignancy

1 reference

12 December 2020

A critical reevaluation of the "therapeutic range" of aminoglycosides

1 reference

12 December 2020

A controlled trial of the cost benefit of computerized bayesian aminoglycoside administration.

1 reference

12 December 2020

Isepamicin in intensive care unit patients with nosocomial pneumonia: population pharmacokinetic-pharmacodynamic study.

1 reference

12 December 2020

Bayesian forecasting of aminoglycoside dosing requirements in obese patients: influence of subpopulation versus general population pharmacokinetic parameters as the internal estimates

1 reference

12 December 2020

Ototoxicity induced by once-daily gentamicin.

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of isepamicin

1 reference

12 December 2020

Aminoglycoside pharmacokinetic monitoring: an integral part of patient care?

1 reference

12 December 2020

Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations

1 reference

12 December 2020

Aminoglycoside volume of distribution and illness severity in critically ill septic patients

1 reference

12 December 2020

Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum

1 reference

12 December 2020

Evaluation of bayesian forecasting for individualized gentamicin dosage in infants weighing 1000 g or less

1 reference

12 December 2020

Estimates of the population pharmacokinetic parameters and performance of Bayesian feedback: a sensitivity analysis.

1 reference

12 December 2020

Experience of once-daily aminoglycoside dosing using a target area under the concentration-time curve

1 reference

12 December 2020

The pharmacodynamics of aminoglycosides

1 reference

12 December 2020

Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients

1 reference

12 December 2020

Once-daily dosing of aminoglycosides. A consensus document

1 reference

12 December 2020

Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosis.

1 reference

12 December 2020

Variability in aminoglycoside pharmacokinetics in critically ill surgical patients

1 reference

12 December 2020

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

1 reference

12 December 2020

1 reference

12 December 2020

Implementation and evaluation of control strategies for individualizing dosage regimens, with application to the aminoglycoside antibiotics

1 reference

12 December 2020

Implementation and evaluation of a stochastic control strategy for individualizing teicoplanin dosage regimen.

1 reference

12 December 2020

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

1 reference

12 December 2020

10.2165/00003088-200140110-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference